Ovoca Bio is a European-based biopharmaceutical company with a focus on women s health. The Company is currently developing a novel treatment for women with hypoactive sexual desire disorder (HSDD). The Company s lead product, BP-101, a novel synthetic peptide administered through a nasal spray, is clinically validated, with Phase II and Phase III studies conducted in Russia demonstrating statistically significant improvement in a number of key efficacy outcomes, including an increase in female sexual desire and reduction of symptoms of distress associated with HSDD. Ovoca Bio is seeking to develop the drug for major global markets - in particular the United States and Europe, as well as obtain marketing approval in the Russian Federation.
QuantuMDx Group Ltd: Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx -
QuantuMDx has developed Q-POC - a rapid, PCR diagnostic device for coronavirus testing at the point of care
NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx Group Limited, a UK-based diagnostics company which has developed a revolutionary 30 minute PCR diagnostics device, Q-POC
, and accompanying SARS-CoV-2 test, today welcomed the Prime Minister, Rt Hon Boris Johnson MP, for a tour of its purpose-built HQ in Newcastle upon Tyne.
Q-POC is an innovative portable, Polymerase Chain Reaction ( PCR ) device offering lab-standard diagnostic testing as the patient waits, with swab-to-result in 30 minutes. This is the same time as a lateral flow test but with PCR accuracy. The Q-POC
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx
February 13, 2021 10:30 ET | Source: QuantuMDx Group Ltd QuantuMDx Group Ltd
Prime Minister, Boris Johnson visits Newcastle-based QuantuMDx
-
QuantuMDx has developed Q-POC™ - a rapid, PCR diagnostic device for coronavirus testing at the point of care
NEWCASTLE UPON TYNE, UK, 13 February 2021. QuantuMDx Group Limited, a UK-based diagnostics company which has developed a revolutionary 30 minute PCR diagnostics device, Q-POC
™, and accompanying SARS-CoV-2 test, today welcomed the Prime Minister, Rt Hon Boris Johnson MP, for a tour of its purpose-built HQ in Newcastle upon Tyne.
Q-POC™ is an innovative portable, Polymerase Chain Reaction (‘PCR’) device offering lab-standard diagnostic testing as the patient waits, with swab-to-result in 30 minutes. This is the same time as a lateral flow test
QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer
QUANTA Appoints Dr Selwayan Saini as Chief Operating Officer
Alcester, Warwickshire, UK, 12 February 2021: QUANTA Dialysis Technologies Ltd (“QUANTA” or the “Company”), a British medical technology pioneer developing innovative dialysis products and services for the global market, today announces the appointment of
Dr Selwayan Saini as Chief Operating Officer with immediate effect.
Dr Saini brings with him over 15 years of experience working in senior operational roles in large global companies and in rapidly growing start-ups. Most recently he was Senior Director of Operations at Oxford Nanopore Technologies and prior to that he held various senior positions including CEO at Medtech Inside Biometrics and Vice President and Worldwide Director at Johnson & Johnson Medical Devices & Diagnostics. While at JNJ, he made significant contributions to chronic health management in the areas of diabetes care, whic